diphenylcyclopropenone has been researched along with Asthma, Bronchial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Häffner, A; Johansen, P; Kündig, TM; Mohanan, D; Senti, G; von Moos, S; Waeckerle-Men, Y | 1 |
| Hengge, UR; Meykadeh, N | 1 |
2 other study(ies) available for diphenylcyclopropenone and Asthma, Bronchial
| Article | Year |
|---|---|
The contact sensitizer diphenylcyclopropenone has adjuvant properties in mice and potential application in epicutaneous immunotherapy.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Alopecia Areata; Anaphylaxis; Animals; Asthma; Cyclopropanes; Desensitization, Immunologic; Disease Models, Animal; Epitopes; Female; Immunoglobulin G; Interleukin-10; Interleukin-4; Lymphocyte Activation; Mice; Mice, Inbred CBA; T-Lymphocytes | 2012 |
[Topical immunomodulators in dermatology].
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aged; Aged, 80 and over; Aminoquinolines; Asthma; Autoimmune Diseases; Bowen's Disease; Child; Cyclopropanes; Dermatitis, Atopic; Dinitrochlorobenzene; Female; Follow-Up Studies; Herpes Simplex; Humans; Imidazoles; Imiquimod; Immunity, Cellular; Immunocompromised Host; Immunoglobulin A; Immunosuppressive Agents; Lichen Sclerosus et Atrophicus; Male; Molluscum Contagiosum; Papillomavirus Infections; Precancerous Conditions; Skin Diseases; Skin Diseases, Viral; Skin Neoplasms; Tacrolimus; Time Factors; Warts | 2003 |